The signaling properties and functions of protease-activated receptor (PAR)1 and PAR2 in cardiomyocytes

被引:0
|
作者
Sabri, A
Andrade-Gordon, P
Darrow, AL
Johnson, RW
Franke, TF
Steinberg, SF
机构
[1] Columbia Univ, New York, NY USA
[2] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
28
引用
收藏
页码:6 / 6
页数:1
相关论文
共 50 条
  • [21] Deficiency of protease-activated receptor (PAR) 1 and PAR2 exacerbates collagen-induced arthritis in mice via differing mechanisms
    Xue, Meilang
    Lin, Haiyan
    Liang, Hai Po Helena
    McKelvey, Kelly
    Zhao, Ruilong
    March, Lyn
    Jackson, Christopher
    RHEUMATOLOGY, 2021, 60 (06) : 2990 - 3003
  • [22] Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries
    Hamilton, JR
    Moffatt, JD
    Frauman, AG
    Cocks, TM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (01) : 108 - 119
  • [23] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [24] Protease-activated receptors PAR2 and PAR3, but not PAR4 are expressed in neuroblastoma cells.
    Wermes, C
    Siebke, A
    Wilhelm, C
    Glüer, S
    Sykora, KW
    Welte, K
    Ganser, A
    von Depka, M
    BLOOD, 2001, 98 (11) : 78B - 78B
  • [25] Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
    McLaughlin, Joseph N.
    Patterson, Myla M.
    Malik, Asrar B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (13) : 5662 - 5667
  • [26] Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice
    Hennessey, John C.
    McGuire, John J.
    PLOS ONE, 2013, 8 (02):
  • [27] Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)
    Shearer, Andrew M.
    Austin, Karyn
    Guha, Srijoy
    Nga Nguyen
    Looby, Richard
    Clappin, Allyson
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    HEPATOLOGY, 2014, 60 : 587A - 587A
  • [28] Mast cells signal to colonocytes by release of tryptase and activation of protease-activated receptor 2 (par2)
    Saito, T
    Amadesi, S
    Cottrell, GS
    Grady, EF
    Bunnett, NW
    GASTROENTEROLOGY, 2005, 128 (04) : A192 - A192
  • [29] Mast cells induce epithelial barrier dysfunction by activation of protease-activated receptor 2 (PAR2)
    Grady, EF
    Yang, PC
    Amadesi, S
    Jacob, C
    Cottrell, GS
    Singh, P
    Darmoul, D
    Perdue, M
    Bunnett, NW
    GASTROENTEROLOGY, 2004, 126 (04) : A519 - A519
  • [30] PROTEASE-ACTIVATED RECEPTOR (PAR) 1 AND PAR2 HAVE OPPOSING EFFECTS ON B-LYMPHOCYTE FUNCTION DURING DIFFERENT STAGES OF MATURATION
    McKelvey, K.
    Chan, Y.
    Jackson, C.
    Xue, M.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 17 - 17